BELLUS Health Announces Positive Results from its Phase 1 Bi

Once-daily Extended-Release formulation demonstrated equivalent bioavailability to twice-daily Immediate Release formulation


Extended-Release formulation was well tolerated, with the safety profile... | April 5, 2023

Related Keywords

United Kingdom , United States , Canada , Canadian , Roberto Bellini , Health Inc , Nasdaq , European Union , Exchange Commission , Immediate Release , Chief Executive Officer , Securities Litigation Reform Act , Annual Information Form , United States Securities , Annual Report , Bellus Health Inc Stock Exchange , News , Information , Press Release , Formulation , Remonstrated , Equivalent , Bioavailability , O , Immediate , Release , Gas , Fell , Ith , The , Afety Blu Ca07987c2040 ,